Conversely, the M2 phenotype is considered cytoprotective, immunosuppressive, and protumorigenic, occurring after M-CSF (expressed by glioma cells, as well as normal human astrocytes), IL-4, IL-10 and/or IL-13 exposure. Here, IL10 is linked to glioma.